论文部分内容阅读
肝细胞癌(Hepatocellular carcinoma,HCC)是全球范围内最常见恶性肿瘤之一。在大多数病例中,HCC是在肝硬化基础上发展而成的。因此肝硬化患者在人口中构成了高的发病风险。通过超声检查和胎甲球蛋白测定进行快速筛选,可以发现早期和无症状期的HCC。需要强调的是HCC患者的预后不仅取决于HCC分期,而且取决于肝脏的基本功能状况。评价标准涉及到肝硬化的基本病变(腹水、血浆钠浓度、肾损害、凝血酶原时间、胆红素、白蛋白等)和HCC分期(结节数量和大小、血管浸润、肝外转移、存在的症状等)。
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. In most cases, HCC is based on cirrhosis. Therefore, patients with cirrhosis constitute a high risk of morbidity in the population. Early screening and asymptomatic HCC can be detected by rapid screening by ultrasound examination and fetogamma assay. It should be emphasized that the prognosis of HCC patients depends not only on the HCC stage but also on the basic functional status of the liver. Evaluation criteria related to the basic lesions of cirrhosis (ascites, plasma sodium concentration, renal damage, prothrombin time, bilirubin, albumin, etc.) and HCC stage (nodule number and size, vascular invasion, extrahepatic metastasis, presence Symptoms, etc.).